Comparison hs Troponin, CKMB and Cholesterol LDL in Acute Myocardial Infarction Patients with and without Diabetes Mellitus
Perbandingan antara hs Troponin, CKMB dan LDL Kolesterol pada Pasien Infark Miokard Akut disertai Diabetes Mellitus dan tidak disertai Diabetes Mellitus
DOI:
https://doi.org/10.21070/ups.5505Keywords:
Acute Myocardial Infarction, Diabetes Mellitus, hs Troponin, CKMB, LDL CholesterolAbstract
Acute Myocardial Infarction (AMI) is one of the leading causes of death in developed countries. hs troponin, creatine kinase muscle and brain (CKMB), and Creatine Kinase (CK) are widely used biomarkers for detecting AMI. Type 2 Diabetes Mellitus (DM) is known to alter the utilization of lipids and lipoproteins, triggering atherogenic dyslipidemia and resulting in atherosclerosis. This study uses a cross-sectional approach to analyze the differences between hs troponin, CKMB, and LDL cholesterol in AMI patients with and without diabetes mellitus. The research was conducted in May 2024 at Saiful Anwar General Hospital. The sample consist of 50 samples, with 25 samples from myocardial infarction (MI) patients accompanied by diabetes mellitus (DM) and 25 samples without DM. The obtained data were tested using the Independent T test and the Mann-Whitney U test.The results showed significant differences in troponin, CKMB, and LDL cholesterol levels in AMI patients with and without DM
Downloads
References
H. Khalil, “Traditional and novel diagnostic biomarkers for acute myocardial infarction,” Egypt J Intern Med, vol. 34, no. 1, 2022, doi: 10.1186/s43162-022-00178-w.
Oren J. Mechanic; Michael Gavin; Shamai A. Grossman., Acute Myocardial Infarction. 2023. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK459269/
World Heart Federation, “World Heart Report 2023: Confronting the World’s Number One Killer,” pp. 1–52, 2023.
Dinas Kesehatan Provinsi Jawa Timur, Profil Kesehatan Provinsi Jawa Timur Tahun 2022. 2022.
A. Salim, M. Suryaatmadja, and D. Hanafi, “Pemeriksaan Ckmb Dan hs-Troponin T Pada Pasien Infark Jantung Dengan Peningkatan Segmen Non-St,” Indonesian Journal of Clinical Pathology and Medical Laboratory, vol. 20, no. 2, pp. 160–167, 2018, doi: 10.24293/ijcpml.v20i2.1086.
A. K. Munta, V. Raghavan, R. M. Gorle, and S. J. Basha, “Cardiac Biomarkers and their Importance in the Diagnosis of Myocardial Ischemia and Acute Myocardial Infarction,” Indian journal of Medical Biochemistry, vol. 22, no. 1, pp. 78–84, 2018, doi: 10.5005/jp-journals-10054-0060.
J. Cui, Y. Liu, Y. Li, F. Xu, and Y. Liu, “Type 2 Diabetes and Myocardial Infarction: Recent Clinical Evidence and Perspective,” Front Cardiovasc Med, vol. 8, no. February, pp. 1–8, 2021, doi: 10.3389/fcvm.2021.644189.
I. Bonilha, E. Hajduch, B. Luchiari, W. Nadruz, W. Le Goff, and A. C. Sposito, “The reciprocal relationship between LDL metabolism and type 2 diabetes mellitus,” Metabolites, vol. 11, no. 12, 2021, doi: 10.3390/metabo11120807.
K. J. Purba, A. Tjiptaningrum, and S. Mustofa, “Gambaran Profil Lipid Pasien Infark Miokardium Akut di RSUD DR. H. Abdul Moeloek Lampung tahun 2021,” Medical Profession Journal of Lampung, vol. 13, no. 1, pp. 151–157, 2023, doi: 10.53089/medula.v13i1.573.
Y. Chen et al., “The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease,” Ren Fail, vol. 45, no. 1, p., 2023, doi: 10.1080/0886022X.2023.2220420.
M. Malhotra and F. Ahmed, “Correlation between CK-MB, TSH, LDL, HDL, Troponin T, Troponin I and myocardial infarction,” Int J Health Sci (Qassim), vol. 6, no. March, pp. 5645–5650, 2022, doi: 10.53730/ijhs.v6ns4.9360.
S. Kumar, J. Jain, K. Singh, and P. Gautam, “Analysis Of Biochemical Markers In Diabetic Non-Diabetic Acute Infarction Patients,” pp. 11–14, 2023, doi: 10.47009/jamp.2023.5.5.3.
L. Oktabelia, D. Anggraini, and H. Ashan, “Hubungan Kadar Glukosa Darah Puasa Dengan Troponin I Pada Pasien Infark Miokard Akut,” An-Nadaa Jurnal Kesehatan Masyarakat, vol. 9, no. 2, p. 215, 2022, doi: 10.31602/ann.v9i2.9235.
D. Care and S. S. Suppl, “10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022,” Diabetes Care, vol. 45, no. January, pp. S144–S174, 2022, doi: 10.2337/dc22-S010.
S. Šimić, T. Svaguša, I. Prkačin, and T. Bulum, “Relationship between hemoglobin A1c and serum troponin in patients with diabetes and cardiovascular events,” J Diabetes Metab Disord, vol. 18, no. 2, pp. 693–704, 2019, doi: 10.1007/s40200-019-00460-9.
R. I. Mahmud, N. K. Nnamah, A. A. Sabir, K. B. Sada, and I. Jelani, “Serum Levels Of Cardiac Troponin I, Creatine Kinase In Patients With Type 2 Diabetes Mellitus And Hytpertensive Co-Mobidity In Uduth, Sokoto State, Nigeria,” Bayero Journal of Medical Laboratory Science BJMLS, vol. 5, pp. 193–200, 2020.
F. Hussien and K. Abdinibi, “Evaluation of Lipid Parameters in Diabetic and Non-Diabetic Acute Myocardial Infarction Patients in Al-Bayda,” vol. 6, no. April, pp. 327–330, 2023.
K. Supriami, I. Puspitawati, D. S. Mayasari, and A. B. Hartopo, “Increased Platelet-derived Microparticles Counts is Correlated with Elevated Blood LDL Cholesterol in Acute Myocardial Infarction,” Indonesian Biomedical Journal, vol. 14, no. 3, pp. 261–268, 2022, doi: 10.18585/inabj.v14i3.1892.
Downloads
Additional Files
Posted
License
Copyright (c) 2024 UMSIDA Preprints Server
This work is licensed under a Creative Commons Attribution 4.0 International License.
